Unibest
← Back to patent-cliff list

CAS 1446094-54-7

(3S,4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a-hydroxy-3-methyl-7-oxo-9-((2-(trimethylsilyl)ethoxy)methoxy)-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium iodide

Codes: METHB-013

Application context (from source-drug indications)

Opioid dependenceMethylnaltrexone BromideConstipationMethylnaltrexone BromideOpioid-induced constipationMethylnaltrexone BromideChronic painMethylnaltrexone BromidePancreatic cancerMethylnaltrexone BromideIntestinal obstructionMethylnaltrexone Bromide

Source drugs (routes using this intermediate)

DrugTierExpiry
Methylnaltrexone BromideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Methylnaltrexone BromideOptimised routesteps: 3total yield: 5.2 g

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.